Study of External Beam Radiation Therapy With and Without Hormonal Therapy to Treat Prostate Cancer

PHASE3CompletedINTERVENTIONAL
Enrollment

206

Participants

Timeline

Start Date

September 30, 1995

Primary Completion Date

April 30, 2001

Study Completion Date

February 28, 2015

Conditions
Prostate Cancer
Interventions
DRUG

Flutamide (Eulexin) and Lupron or Zoladex

Androgen suppression therapy

RADIATION

External Beam Radiotherapy

Once a day, 4-5 days per week for approximately 2 months

Trial Locations (1)

02115

Dana-Farber Cancer Institute, Boston

All Listed Sponsors
collaborator

Brigham and Women's Hospital

OTHER

collaborator

Saint Anne's Hospital

OTHER

collaborator

Beth Israel Deaconess Medical Center

OTHER

collaborator

Metro West Medical Center

OTHER

lead

Dana-Farber Cancer Institute

OTHER

NCT00116220 - Study of External Beam Radiation Therapy With and Without Hormonal Therapy to Treat Prostate Cancer | Biotech Hunter | Biotech Hunter